drugset / Trial / NCT03878589

Understanding Cognition, Oxytocin & Pain in Elders

NCT03878589

RandomizedCrossoverQuadruple-blindTreatment

Summary

Osteoarthritis (OA) represents a significant cause of disability worldwide and the knee is the most commonly affected joint. Oxytocin (OT) is a mediator of endogenous analgesia in animal and human studies. This proposal will test the efficacy and safety of self-administered intranasal OT over 4-weeks in older individuals relative to placebo (P) evaluating its effects on pain and function in aging and testing potential underlying neurobiological mechanisms.

Timeline

Start
2019-08-06
Primary completion
2024-12-19
Completion
2024-12-19

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxytocin Peptide 24 iu Intranasal

Indications